{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T13:09:12Z","timestamp":1782306552381,"version":"3.54.5"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T00:00:00Z","timestamp":1595462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T00:00:00Z","timestamp":1595462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>The risk of life-threatening complications, such as visceral disseminated varicella zoster virus (VZV) infection, is greater in immunosuppressed individuals, such as systemic lupus erythematosus (SLE) patients.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>Here, a case is reported of a Caucasian woman diagnosed with lupus nephritis and anti-phospholipid syndrome, who was subjected to mycophenolate mofetil and high-dose steroid remission-induction therapy. Two months later she developed abdominal pain followed by a fatal rapid multi-organ failure. As no typical skin rashes were evident, death was initially attributed to catastrophic anti-phospholipid syndrome. However, autopsy and virological examinations on archival material revealed a disseminated VZV infection.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Overall, this case highlights the importance of having a high clinical suspicion of fatal VZV infections in heavily immunosuppressed SLE patients even when typical signs and symptoms are lacking.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12879-020-05254-6","type":"journal-article","created":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T11:04:10Z","timestamp":1595502250000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Unusual presentation of fatal disseminated varicella zoster virus infection in a patient with lupus nephritis: a case report"],"prefix":"10.1186","volume":"20","author":[{"given":"Veronica","family":"Vassia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Croce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Ravanini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Leutner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Saglietti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Fangazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Quaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3338-5416","authenticated-orcid":false,"given":"Carlo","family":"Smirne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,23]]},"reference":[{"issue":"Suppl 1","key":"5254_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1086\/342963","volume":"186","author":"JW Gnann Jr","year":"2002","unstructured":"Gnann JW Jr. Varicella-zoster virus: atypical presentations and unusual complications. J Infect Dis. 2002;186(Suppl 1):91\u20138.","journal-title":"J Infect Dis"},{"key":"5254_CR2","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1136\/jcp.49.3.243","volume":"49","author":"AF Nikkels","year":"1996","unstructured":"Nikkels AF, Delvenne P, Sadzot-Delvaux C, Debrus S, Piette J, Rentier B, et al. Distribution of varicella zoster virus and herpes simplex virus in disseminated fatal infections. J Clin Pathol. 1996;49:243\u20138.","journal-title":"J Clin Pathol"},{"key":"5254_CR3","first-page":"321","volume":"100","author":"D Lewis","year":"2017","unstructured":"Lewis D, Schlichte M, Dao H. Atypical disseminated herpes zoster: management guidelines in Immunocompromised patients. Cutis. 2017;100:321\u2013324,330.","journal-title":"Cutis"},{"key":"5254_CR4","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/RHU.0b013e3181d52ed7","volume":"16","author":"EF Borba","year":"2010","unstructured":"Borba EF, Ribeiro AC, Martin P, Costa LP, Guedes LK, Bonf\u00e1 E. Incidence, risk factors, and outcome of herpes zoster in systemic lupus erythematosus. J Clin Rheumatol. 2010;16:119\u201322.","journal-title":"J Clin Rheumatol"},{"key":"5254_CR5","doi-asserted-by":"publisher","unstructured":"Sayeeda A, Al Arfaj H, Khalil N, Al Arfaj AS. Herpes zoster infections in SLE in a University Hospital in Saudi Arabia: risk factors and outcomes. Autoimmune Dis. 2010. https:\/\/doi.org\/10.4061\/2010\/174891.","DOI":"10.4061\/2010\/174891"},{"key":"5254_CR6","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1002\/art.38804","volume":"66","author":"C Rondaan","year":"2014","unstructured":"Rondaan C, de Haan A, Horst G, Hempel JC, van Leer C, Bos NA, et al. Altered cellular and humoral immunity to varicella-zoster virus in patients with autoimmune diseases. Arthritis Rheumatol. 2014;66:3122\u20138.","journal-title":"Arthritis Rheumatol"},{"key":"5254_CR7","first-page":"2151","volume":"31","author":"HB Park","year":"2004","unstructured":"Park HB, Kim KC, Park JH, Kang TY, Lee HS, Kim TH, et al. Association of reduced CD4 T cell responses specific to varicella zoster virus with high incidence of herpes zoster in patients with systemic lupus erythematosus. J Rheumatol. 2004;31:2151\u20135.","journal-title":"J Rheumatol"},{"key":"5254_CR8","first-page":"6222","volume":"14","author":"D Chen","year":"2017","unstructured":"Chen D, Li H, Xie J, Zhan Z, Liang L, Yang X. Herpes zoster in patients with systemic lupus erythematosus: clinical features, complications and risk factors. Exp Ther Med. 2017;14:6222\u20138.","journal-title":"Exp Ther Med"},{"key":"5254_CR9","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1177\/0961203312470186","volume":"22","author":"EF Chakravarty","year":"2013","unstructured":"Chakravarty EF, Michaud K, Katz R, Wolfe F. Incidence of herpes zoster among patients with systemic lupus Erythematosus. Lupus. 2013;22:238\u201344.","journal-title":"Lupus"},{"key":"5254_CR10","doi-asserted-by":"publisher","unstructured":"Meirinhos T, Mariz E, Castro Ferreira I, Neto R, Pereira E, Costa L. AB0424 Retrospective Evaluation of Mycophenolate Mofetil Infectious Side Effects on Lupus Nephritis Patients. Ann Rheum Dis. 2016. https:\/\/doi.org\/10.1136\/annrheumdis-2016-eular.5961.","DOI":"10.1136\/annrheumdis-2016-eular.5961"},{"key":"5254_CR11","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1191\/096120301682430186","volume":"10","author":"EJ Kingdon","year":"2001","unstructured":"Kingdon EJ, McLean AG, Psimenou E, Davenport A, Powis SH, Sweny P, et al. The safety and efficacy of MMF in lupus nephritis: a pilot study. Lupus. 2001;10:606\u201311.","journal-title":"Lupus"},{"key":"5254_CR12","doi-asserted-by":"publisher","unstructured":"Henderson L, Masson P, Craig JC, Flanc RS, Roberts MA, Strippoli GF, et al. Treatment for lupus nephritis. Cochrane Database Syst Rev. 2012. https:\/\/doi.org\/10.1002\/14651858.CD002922.pub3.","DOI":"10.1002\/14651858.CD002922.pub3"},{"key":"5254_CR13","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13104-018-3271-3","volume":"11","author":"M Habuka","year":"2018","unstructured":"Habuka M, Wada Y, Kurosawa Y, Yamamoto S, Tani Y, Ohashi R, et al. Fatal visceral disseminated varicella zoster infection during initial remission induction therapy in a patient with lupus nephritis and rheumatoid arthritis-possible association with mycophenolate mofetil and high-dose glucocorticoid therapy: a case report. BMC Res Notes. 2018;11:165.","journal-title":"BMC Res Notes"},{"key":"5254_CR14","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3892\/ol.2016.4683","volume":"12","author":"HS Okuma","year":"2016","unstructured":"Okuma HS, Kobayashi Y, Makita S, Kitahara H, Fukuhara S, Munakata W, et al. Disseminated herpes zoster infection initially presenting with abdominal pain in patients with lymphoma undergoing conventional chemotherapy: a report of three cases. Oncol Lett. 2016;12:809\u201314.","journal-title":"Oncol Lett"},{"key":"5254_CR15","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1016\/j.ijid.2008.06.036","volume":"13","author":"MM Balkis","year":"2009","unstructured":"Balkis MM, Ghosn S, Sharara AI, Atweh SF, Kanj SS. Disseminated varicella presenting as acute abdominal pain nine days before the appearance of the rash. Int J Infect Dis. 2009;13:e93\u20135.","journal-title":"Int J Infect Dis"},{"key":"5254_CR16","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1128\/JCM.40.6.2302-2304.2002","volume":"40","author":"MJ Curley","year":"2002","unstructured":"Curley MJ, Hussein SA, Hassoun PM. Disseminated herpes simplex virus and varicella zoster virus coinfection in a patient taking thalidomide for relapsed multiple myeloma. J Clin Microbiol. 2002;40:2302\u20134.","journal-title":"J Clin Microbiol"},{"key":"5254_CR17","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1097\/CCM.0000000000000969","volume":"43","author":"P Lopez Roa","year":"2015","unstructured":"Lopez Roa P, Hill JA, Kirby KA, Leisenring WM, Huang ML, Santo TK, et al. Coreactivation of human Herpesvirus 6 and Cytomegalovirus is associated with worse clinical outcome in critically ill adults. Crit Care Med. 2015;43:1415\u201322.","journal-title":"Crit Care Med"},{"key":"5254_CR18","doi-asserted-by":"publisher","unstructured":"Grinde B. Herpesviruses: latency and reactivation - viral strategies and host response. J Oral Microbiol. 2013. https:\/\/doi.org\/10.3402\/jom.v5i0.22766.","DOI":"10.3402\/jom.v5i0.22766"},{"key":"5254_CR19","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1086\/426402","volume":"191","author":"A Weinberg","year":"2005","unstructured":"Weinberg A, Bloch KC, Li S, Tang YW, Palmer M, Tyler KL. Dual infections of the central nervous system with Epstein-Barr virus. J Infect Dis. 2005;191:234\u20137.","journal-title":"J Infect Dis"},{"key":"5254_CR20","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1089\/aid.1995.11.1241","volume":"11","author":"L Cuomo","year":"1995","unstructured":"Cuomo L, Angeloni A, Zompetta C, Cirone M, Calogero A, Frati L, et al. Human herpesvirus 6 variant a, but not variant B, infects EBV-positive B lymphoid cells, activating the latent EBV genome through a BZLF-1-dependent mechanism. AIDS Res Hum Retrovir. 1995;11:1241\u20135.","journal-title":"AIDS Res Hum Retrovir"},{"key":"5254_CR21","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1128\/JVI.70.3.1784-1791.1996","volume":"70","author":"L Flamand","year":"1996","unstructured":"Flamand L, Menezes J. Cyclic AMP-responsive element-dependent activation of Epstein-Barr virus zebra promoter by human herpesvirus 6. J Virol. 1996;70:1784\u201391.","journal-title":"J Virol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05254-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-020-05254-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05254-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T23:12:23Z","timestamp":1626995543000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05254-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,23]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5254"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05254-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,23]]},"assertion":[{"value":"6 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent to publish the case was obtained from the next of kin of the patient (concerning his relative\u2019s personal or clinical details along with any identifying images to be published in this study).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"538"}}